DepoMed, Inc. (DEPO) Tops Q3 EPS by 7c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/7/2026
- S&P 500, Nasdaq retreat from record highs as yields and oil climb
- Want to be a stock market bear? BCA says watch potential U.S. tax increases
- SpaceX seeks $40bn in financing for Nvidia chip purchase
- Chip stock could soar nearly 200%, analyst says: "If you don’t buy it, they will"
- Musk rules out TSMC role in Terafab operations; Intel gains
Tweet
Share
E-mailGet Alerts DEPO Hot Sheet
Price: $7.30 --0%
Financial Fact:
Total costs and expenses: 109.27M
Today's EPS Names:
AEHR, VFS, CMTL, More
Financial Fact:
Total costs and expenses: 109.27M
Today's EPS Names:
AEHR, VFS, CMTL, More
Join SI Premium – FREE
DepoMed, Inc. (NASDAQ: DEPO) reported Q3 EPS of ($0.15), $0.07 better than the analyst estimate of ($0.22). Revenue for the quarter came in at $16.52 million versus the consensus estimate of $10.4 million.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Constellation Brands (STZ) Beats Q2 EPS by 13c, Revenue Beats, Offers Guidance
- Jabil (JBL) Tops Q4 EPS by 34c, Beats on Revenue; Offers FY Guidance
- Lamb Weston shares jump 3% on Q1 beat-and-raise
Create E-mail Alert Related Categories
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
